SEC Company Response from ADIAL PHARMACEUTICALS, INC. (ADIL) (CIK 0001513525) (AZR) — Feb 13, 2019

ADIAL PHARMACEUTICALS, INC. (ADIL) (CIK 0001513525)
Date: Feb. 13, 2019 · CIK: 0001513525 · Accession: 0001213900-19-002312

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-229615

Date

February 13, 2019

Author

William B. Stilley III

Form

CORRESP

Company

ADIAL PHARMACEUTICALS, INC. (ADIL) (CIK 0001513525)

Letter

VIA EDGAR United States Securities Division of Corporation Finance Attention: Mr. Todd Schiffman Re: Adial Pharmaceuticals, Inc. Withdrawal of Acceleration Request Registration Statement on Form S-1 File No: 333-229615

Dear Mr. Schiffman:

Adial Pharmaceuticals, Inc. (the “Registrant”) hereby respectfully requests withdrawal of its acceleration request letter filed as correspondence via EDGAR on February 12, 2019, which requested that the above-referenced Registration Statement on Form S-1 (File No. 333-229615) become effective on Thursday, February 14, 2019, at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable. The Registrant is no longer requesting that such Registration Statement be declared effective at this time and the Registrant hereby formally withdraws its request for acceleration of the effective date.

If you have any questions regarding the foregoing, please contact our counsel, Leslie Marlow of Gracin & Marlow, LLP, at (516) 496-2223 or (212) 907-6457.

Very truly yours,
ADIAL PHARMACEUTICALS, INC.

Show Raw Text

CORRESP
1
filename1.htm

Adial Pharmaceuticals, Inc.

1001 Research Park Blvd., Suite 100

Charlottesville, Virginia 22911

February 13, 2019

VIA EDGAR

United States Securities

    and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Mr. Todd Schiffman

    Re:
    Adial Pharmaceuticals, Inc.

        Withdrawal of Acceleration Request

        Registration Statement on Form S-1

        File No: 333-229615

Dear Mr. Schiffman:

Adial Pharmaceuticals,
Inc. (the “Registrant”) hereby respectfully requests withdrawal of its acceleration request letter filed as
correspondence via EDGAR on February 12, 2019, which requested that the above-referenced Registration Statement on Form S-1 (File
No. 333-229615) become effective on Thursday, February 14, 2019, at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant is no longer requesting that such Registration Statement be declared effective at this time and the Registrant hereby
formally withdraws its request for acceleration of the effective date.

If you have any
questions regarding the foregoing, please contact our counsel, Leslie Marlow of Gracin & Marlow, LLP, at (516) 496-2223 or
(212) 907-6457.

    Very truly yours,

    ADIAL PHARMACEUTICALS, INC.

    By:
    /s/ Willian B. Stilley III

    Name:
    William B. Stilley III

    Title:
    Chief Executive Officer

    cc:
    Leslie Marlow, Esq., Gracin & Marlow, LLP

SecProbe.io